
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global biosimulation market size was valued at USD 3.50 Billion in 2024, with Europe holding a significant market share. The market is driven by technological advancements in biosimulation platforms and tools. It is expected to grow at a CAGR of 16.90% during the forecast period of 2025-2034, with the values likely to attain USD 16.68 Billion by 2034.
Base Year
Historical Year
Forecast Year
Recent data suggests that 25% of all annual cancer cases occur in Europe, with nearly half of the population at risk of developing cancer at some point in their lives . The rising emphasis on accelerating oncology drug development, fuelled by the growing number of cancer cases, is expected to surge market demand.
One of the major Europe biosimulation market trends is the increased collaborative initiatives among the key market players to utilize biosimulation platforms in clinical applications. In March 2024, Exploristics and Exonate Ltd announced a successful collaboration involving the optimisation of clinical trial designs for Exonate’s upcoming Phase IIb study by leveraging Exploristics’ KerusCloud (a simulation-guided study design platform).
In March 2023, Certara, Inc., announced the launch of Simcyp™ PBPK Simulator Version 22, adding novel and updating existing features of its population-based modeling and simulation platform. The launch of such technologically advanced biosimulation systems is likely to elevate market value.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Europe Biostimulation Market Size
Europe Biostimulation Market Analysis
Europe Biostimulation Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The Europe biosimulation market is expected to be driven by the rising demand for the global biosimulation market, which is anticipated to grow at a CAGR of 16.90% during the forecast period of 2025-2034 and is likely to reach a market value of USD 16.68 Billion by 2034.
The growing prevalence of chronic diseases and the rising healthcare expenditure are fuelling the demand for the market.
One of the significant trends in the market is the increased collaborative initiatives among the key market players to utilize biosimulation platforms in clinical applications. In March 2024, Exploristics and Exonate Ltd announced a successful collaboration involving optimizing the clinical trial design for Exonate’s upcoming Phase IIb study by leveraging a simulation-guided platform.
Based on the product type, the market is segmented into services and software.
By delivery type, the market is divided into the subscription model and ownership model.
End users of the market are biotechnology & pharmaceutical companies, research institutes, regulatory authorities, and contract research organizations.
Major applications of biosimulation include drug development and drug discovery, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy.
The key players in the market are Dassault Systèmes, Schrödinger, Physiomics Plc, Simulations Plus, Insilico Biotechnology, Genedata, Argenx, CureVac SE, INOSIM Software GmbH, and Certara.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124